The company aims to enhance the quality of analysis they can already provide, scale-up clinical trial insights, as well as fund natural language processing projects.
The G-Tech WPS is a tool that provides gastric and intestinal myoelectrical activity measurements to aid in the diagnosis and evaluation of gastrointestinal disorders.
One of the few molecular diagnostics laboratories focused on research and development for women’s health to earn the prestigious accreditation.
Partnership to focus on improving patient outcomes while reducing healthcare system costs of expensive biologic therapeutics.
Allara offers the first end-to-end chronic care management platform for women with polycystic ovary syndrome.
Founded by 2 elite athletes and Stanford engineering students, Sequel has also raised $5M in funding.
Oshi Health’s integrated GI care model provides effective relief through evidence-based, whole-person care.
BICO has also invested $400,000 into Nanochon’s seed funding round to advance its regenerative medicine technology.
This partnership will enable iCAD to add Arterys’ FDA-cleared MICA platform to its installed base and give providers access to their software from anywhere in the world.
Alio leverages artificial intelligence and its SmartPatch sensor technology to non-invasively monitor vascular access health and other chronic conditions faced by end-stage renal disease patients.